Patient recruitment in rare disease clinical trials presents several difficulties. These challenges include limited eligible patients, dispersed geographic distribution, low disease awareness, site and investigator identification difficulties, and ethical considerations. They hinder participant enrollment and cause trial completion delays. Over the past few years, the rate of drug development in rare diseases has been increasing. […]

Read More →

The development of drugs in rare diseases provides great opportunities to pharma companies along with challenges that are required to overcome during drug discovery, pre-clinical, and clinical stages of drug development. Commercially rare diseases drug development differs from traditional diseases, as there are considerably few patients to take the drug, therefore pharmaceutical companies should consider […]

Read More →

A case record form (CRF) is a great and necessary tool used in clinical trials to collect data from each participating patient. CRF (also referred to as case report form) has historically been on paper (unlike electronic ones these days). Traditionally, something like carbon copy paper, where the sponsor can utilize one sheet for the Trial Master […]

Read More →

Conducting clinical trial feasibility is one of the first and crucial steps involved in any clinical study process. Clinical trial feasibility helps in assessing the potential of investigators, the country’s potential for conducting the trial, and many more aspects involved to execute a clinical trial successfully. Clinical trial feasibility Clinical trial feasibility is an assessment […]

Read More →

Clinical trial feasibility is a process to evaluate the possibility of conducting a clinical trial in a particular region, specific medical centers/site with an objective of optimum project completion in terms of timelines, targets and cost. This forms an integral and unavoidable step in beginning any clinical trial. Clinical trial feasibility is always facilitated by […]

Read More →

Identification and selection of clinical trial sites and clinical investigators remain one of the first and most crucial decisions that clinical trial managers take. This also happens to be the one that may define the success (or, failure) of the project. We had been seeing the impact of site/investigator identification on clinical trial successes time […]

Read More →

Clinical research is an indispensable section of human healthcare today. It forms the major part of any drug development effort and thousands of doctors and scientists worldwide actively engage in it. Trial Managers – Investigators Trial managers, monitors, research associates, site specialists, site identification and selection teams are always in search of experienced, qualified, and […]

Read More →